nocodazole has been researched along with dactinomycin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Hino, Y; Minakami, S; Nagata-Kuno, K; Nanri, H; Shibata, Y | 1 |
| Alvarez, CV; Dieguez, C; Domínguez, F; Vega, FV; Vidal, A; Zalvide, JB | 1 |
| Haremaki, T; Sugai, T; Takahashi, M | 1 |
| Chhatwal, GS; Jungnitz, H; Rohde, M; Valentin-Weigand, P; Zock, A | 1 |
| Brandeis, M; Inbal, N; Listovsky, T | 1 |
| Dipple, A; Khan, QA | 1 |
| Harvey, KJ; Lukovic, D; Ucker, DS | 1 |
| Anderson, LM; Khan, QA | 1 |
| Anderson, LM; Dipple, A; Khan, QA | 1 |
| Guo, X; Guo, Y; Li, Y; Shen, B; Sun, D; Wang, J; Zhang, J; Zhang, X | 1 |
12 other study(ies) available for nocodazole and dactinomycin
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Fragmentation of re-formation of mitotic Golgi apparatus detected by a centrifugal method.
Topics: Animals; Cells, Cultured; Centrifugation, Density Gradient; Cricetinae; Cricetulus; Cycloheximide; Dactinomycin; Female; Galactosyltransferases; Golgi Apparatus; Interphase; Microscopy, Electron; Mitosis; Nocodazole; Ovary; Vinblastine | 1990 |
Regulation of thymosin beta 4 mRNA levels during cell proliferation.
Topics: Animals; Blotting, Northern; Cell Cycle; Cell Division; Cell Line; Cycloheximide; Dactinomycin; Fibroblasts; G1 Phase; Gene Expression Regulation, Developmental; Mice; Mitosis; Nocodazole; RNA, Messenger; S Phase; Thymosin | 1995 |
Involvement of active cellular mechanisms on the disorganization of oral apparatus in amicronucleate cells in Tetrahymena thermophila.
Topics: Animals; Cell Division; Cell Nucleus; Cold Temperature; Cycloheximide; Dactinomycin; Nocodazole; Tetrahymena thermophila | 1996 |
Characterization of group B streptococcal invasion in HEp-2 epithelial cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cadaverine; Calcium; Cells, Cultured; Cytoskeleton; Dactinomycin; Enzyme Inhibitors; Epithelium; Genistein; Humans; Isoflavones; Liver; Microscopy, Electron; Microscopy, Electron, Scanning; Nocodazole; Signal Transduction; Staurosporine; Streptococcal Infections; Streptococcus agalactiae; Virulence | 1997 |
The mammalian Fizzy and Fizzy-related genes are regulated at the transcriptional and post-transcriptional levels.
Topics: 3T3 Cells; Animals; Cdh1 Proteins; Cell Cycle Proteins; Cell Division; Dactinomycin; Gene Expression Regulation; Immunoblotting; Insect Proteins; Mice; Nocodazole; RNA, Messenger; Time Factors; Transcription, Genetic | 1999 |
Diverse chemical carcinogens fail to induce G(1) arrest in MCF-7 cells.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Acetoxyacetylaminofluorene; Alkylating Agents; Breast Neoplasms; Carcinogens; Cell Cycle; Cell Survival; Dactinomycin; Dose-Response Relationship, Drug; G1 Phase; Humans; Methylnitronitrosoguanidine; Nocodazole; Stereoisomerism; Tumor Cells, Cultured | 2000 |
Membrane-targeted green fluorescent protein reliably and uniquely marks cells through apoptotic death.
Topics: Apoptosis; beta-Galactosidase; Biomarkers; Dactinomycin; DNA, Neoplasm; Flow Cytometry; Fluorescence; Green Fluorescent Proteins; HeLa Cells; Humans; Intracellular Membranes; Jurkat Cells; Luminescent Proteins; Mitochondria; Nocodazole; Serpins; Staining and Labeling; Transfection; Viral Proteins | 2001 |
Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Animals; Antineoplastic Agents; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Chrysenes; Dactinomycin; DNA Damage; Epithelial Cells; Flow Cytometry; G1 Phase; Genes, p53; Humans; Lung; Lung Neoplasms; Mice; Mutagens; Mutation; Nocodazole; Nucleic Acid Synthesis Inhibitors; Tumor Cells, Cultured | 2001 |
Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Carcinogens; Cell Cycle; Chrysenes; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Dactinomycin; Epithelial Cells; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Lung; Mice; Nocodazole; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Nocodazole increases the ERK activity to enhance MKP-1expression which inhibits p38 activation induced by TNF-α.
Topics: Animals; Butadienes; Cell Cycle; Cell Line; Dactinomycin; Dual Specificity Phosphatase 1; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Imidazoles; MAP Kinase Kinase 4; Mice; Microtubules; Nitriles; Nocodazole; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; RNA; Signal Transduction; Tubulin; Tumor Necrosis Factor-alpha | 2012 |